✦ LIBER ✦

Clinical effects of pranlukast, an oral leukotriene receptor antagonist, in mild-to-moderate asthma: A 4 week randomized multicentre controlled trial

✍ Scribed by Se Hwa Yoo; Sung Hak Park; Jeong Sup Song; Kyung Ho Kang; Choon Sik Park; Jee Hong Yoo; Byoung Whui Choi; Myung Ho Hahn; Representing Korea Pranlukast Study Group

Book ID: 108964125
Publisher: John Wiley and Sons
Year: 2001
Tongue: English
Weight: 236 KB
Volume: 6
Category: Article
ISSN: 1323-7799
DOI: 10.1111/j.1440-1843.2001.00291.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Apremilast, an oral phosphodiesterase 4

Apremilast, an oral phosphodiesterase 4 inhibitor, in patients with moderate to severe psoriasis: 16-week results of a phase 3, randomized, controlled trial (ESTEEM 2)

📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 49 KB

An over the counter moisturizer is as cl

An over the counter moisturizer is as clinically effective as, and more cost-effective than, prescription barrier creams in the treatment of children with mild to moderate atopic dermatitis: A randomized, controlled trial

📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 44 KB

Efficacy and Tolerability of Fimasartan,

Efficacy and Tolerability of Fimasartan, a New Angiotensin Receptor Blocker, Compared With Losartan (50/100 mg): A 12-Week, Phase III, Multicenter, Prospective, Randomized, Double-Blind, Parallel-Group, Dose Escalation Clinical Trial With an Optional 12-Week Extension Phase in Adult Korean Patients With Mild-to-Moderate Hypertension

✍ Sang Eun Lee; Yong-Jin Kim; Hae-Young Lee; Han-Mo Yang; Chang-Gyu Park; Jae-Joon 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 806 KB